Drug Discovery 2022: driving the next life science revolution

Dr Lisa Mohamet

Dr Lisa Mohamet
Dr Lisa Mohamet
Senior Scientific Director, Head Translational Cell Sciences, Genomic Sciences
GlaxoSmtihKline
Speaker

Presentations at Drug Discovery 2022: driving the next life science revolution

Wed5  Oct11:00am(110 mins)
Chairing:

Session: Developments in Preclinical Models
Room: Auditorium 1
Wed5  Oct11:00am(5 mins)
Session Introduction

Session: Developments in Preclinical Models
Room: Auditorium 1

Profile of Dr Lisa Mohamet

In 2017, Lisa joined GSK preclinical R&D as a Scientific Leader to head up the advanced cellular model platform group to support lead drug discovery programs. In 2018, her team moved to the newly formed Functional Genomics department, where she is Head of Translational Cell Science, leading a team of 30 scientists, with a focus on the application of iPSC-derived cell types, in vivo models and organoids for use in CRISPR screening for target discovery across multiple therapeutic areas. Prior to joining GSK, Lisa was a Royal Society of Edinburgh/BBSRC Research Fellow at The University of Manchester and has over ten years’ experience in human stem cell biology and regenerative medicine. Subsequently, Lisa co-founded StrataStem Ltd, an innovative spin-out biotech company, utilizing stem cell technology to identify stratification opportunities for Alzheimer’s disease. Lisa was named as one of BioBeats’ ‘Rising Stars’ of the top 50 UK women entrepreneurs and leaders in biobusiness in 2016.

Email

Please login to send a Private Message

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the appstore or google play and search for 'elrig'